Medicine for inhibiting dietary obesity and polypeptide used by medicine
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- INST OF ZOOLOGY CHINESE ACAD OF SCI
- Publication Date
- 2022-05-10
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to a polypeptide for suppressing diet-induced obesity and its application. Background technique
[0002] Obesity is defined as a body mass index (BMI) ≥ 30kg / m 2 , global obesity has nearly tripled since 1975. It is estimated that more than 1.9 billion adults were overweight in 2014, of whom more than 600 million were classified as obese. Obesity is now becoming a global epidemic with a high risk of developing non-communicable diseases including type 2 diabetes (T2D), cardiovascular disease, stroke, cancer and depression, among others. Various strategies have been developed to combat obesity and overweight, mainly by reducing energy intake and increasing metabolic expenditure.
[0003] Small peptides are a promising class of molecules whose attractive pharmacological properties and excellent safety, tolerability, and efficacy have attracted increasing attention for their applications in medicine and biotechnology. At present, ...